RT Book, Section
A1 Berman, Daniel S.
A1 Hachamovitch, Rory
A1 Shaw, Leslee J.
A1 Hayes, Sean W.
A1 Slomka, Piotr J.
A1 Germano, Guido
A1 Narula, Jagat
A2 Fuster, Valentin
A2 Harrington, Robert A.
A2 Narula, Jagat
A2 Eapen, Zubin J.
SR Print(0)
ID 1161726382
T1 NUCLEAR CARDIOLOGY
T2 Hurst's The Heart, 14e
YR 2017
FD 2017
PB McGraw-Hill Education
PP New York, NY
SN 9780071843249
LK accessmedicine.mhmedical.com/content.aspx?aid=1161726382
RD 2024/04/25
AB Nuclear  cardiology  is  an  integral  part  of  routine  cardiovascular  practice.  This  chapter  provides  a  synopsis  of  nuclear  cardiology  procedures  and  the  published  evidence  of  their  role  in  the  diagnosis,  risk  assessment,  and  management  of  patients  with  suspected  or  known  coronary  artery  disease  (CAD).  In  the  technical  section,  the  focus  is  on  single-photon  emission  computed  tomography  (SPECT)  since  positron  emission  tomography  (PET)  is  the  subject  of  Chapter  19.  Guidelines  and  appropriate  use  criteria  combine  SPECT  and  PET,  and  considerations  of  the  applications  are  similar;  therefore,  the  clinical  portions  of  this  chapter  discuss  both  approaches.  While  nuclear  cardiology  has  a  broad  potential  role  in  molecular  imaging,  myocardial  perfusion  imaging  (MPI)  with  SPECT  and  PET  makes  up  the  vast  majority  of  current  clinical  nuclear  cardiology  procedures;  hence,  MPI  is  the  primary  subject  of  this  chapter.  In  the  chapter,  CAD  generally  refers  to  the  presence  of  an  obstructive  stenosis,  in  contradistinction  to  coronary  atherosclerosis,  which  is  used  to  denote  the  presence  of  any  atherosclerotic  plaque  in  the  coronary  arteries.  The  term  nuclear  MPI  will  be  used  when  the  discussion  refers  to  both  SPECT  and  PET-MPI  approaches.